{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:39:36Z","timestamp":1789609176370,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm county council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003748","name":"SSMF","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ALF Gothenburg"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.trim.2011.06.001","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T09:44:43Z","timestamp":1309081483000},"page":"153-158","source":"Crossref","is-referenced-by-count":23,"title":["Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"25","author":[{"given":"Anna","family":"Nordlander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Uhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Kumlien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Hauzenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2011.06.001_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/IR:28:1:13","article-title":"The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases","volume":"28","author":"Maris","year":"2003","journal-title":"Immunologic Research"},{"key":"10.1016\/j.trim.2011.06.001_bb0010","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","article-title":"T-cell depletion of HLA-identical transplants in leukemia","volume":"78","author":"Marmont","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbmt.2007.10.025","article-title":"Graft failure after allogeneic hematopoietic cell transplantation","volume":"14","author":"Mattsson","year":"2008","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0020","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1084\/jem.134.6.1513","article-title":"Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice","volume":"134","author":"Cudkowicz","year":"1971","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.trim.2011.06.001_bb0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/eji.1830070915","article-title":"Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts","volume":"7","author":"Kiessling","year":"1977","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.trim.2011.06.001_bb0030","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.166.5.1499","article-title":"Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized","volume":"166","author":"Murphy","year":"1987","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.trim.2011.06.001_bb0035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood.V68.4.861.861","article-title":"Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors","volume":"68","author":"Raff","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0040","first-page":"893","article-title":"Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex","volume":"22","author":"Raff","year":"1994","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.trim.2011.06.001_bb0045","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood.V74.5.1477.1477","article-title":"Antibody-mediated marrow failure after allogeneic bone marrow transplantation","volume":"74","author":"Barge","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.147.3660.873","article-title":"Contact-induced cytotoxicity by lymphoid cells containing foreign isoantigens","volume":"147","author":"Moeller","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.trim.2011.06.001_bb0055","first-page":"245","article-title":"Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia","volume":"13","author":"Warren","year":"1981","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.trim.2011.06.001_bb0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/01.tp.0000235589.66683.0e","article-title":"Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice","volume":"82","author":"Nagata","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0065","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/blood-2006-05-022772","article-title":"Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients","volume":"109","author":"Taylor","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0070","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1182\/blood-2006-04-017467","article-title":"Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients","volume":"108","author":"Xu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0966-3274(97)80016-0","article-title":"Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells","volume":"5","author":"Sumitran-Karuppan","year":"1997","journal-title":"Transplant Immunology"},{"key":"10.1016\/j.trim.2011.06.001_bb0080","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.TP.0000078622.43689.D4","article-title":"Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab","volume":"76","author":"Tyden","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0085","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood-2002-05-1511","article-title":"Identification of the hemangioblast in postnatal life","volume":"100","author":"Pelosi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0090","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nature00821","article-title":"VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism","volume":"417","author":"Gerber","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.trim.2011.06.001_bb0095","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/TP.0b013e3181820333","article-title":"Novel antibodies to the donor stem cell population CD34+\/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation","volume":"86","author":"Nordlander","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/01.tp.0000262570.18117.55","article-title":"Implementation of a Protocol for ABO-incompatible kidney transplantation\u2014a three-center experience with 60 consecutive transplantations","volume":"83","author":"Tyden","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V71.2.293.293","article-title":"Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials","volume":"71","author":"Storb","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2007.05.015","article-title":"Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival","volume":"13","author":"Gluckman","year":"2007","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0115","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/sj.leu.2402311","article-title":"Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation","volume":"15","author":"Mattsson","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.trim.2011.06.001_bb0120","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2007-04-087056","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0125","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1600-6143.2004.00507.x","article-title":"Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy","volume":"4","author":"Sonnenday","year":"2004","journal-title":"American Journal of Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0130","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/01.tp.0000296031.41424.f8","article-title":"Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab","volume":"84","author":"Genberg","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0135","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2011.06.001_bb0140","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2141.2001.03174.x","article-title":"Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation","volume":"115","author":"Mattsson","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.trim.2011.06.001_bb0145","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-3083.2005.01595.x","article-title":"The pathophysiology of acute graft-versus-host disease","volume":"61","author":"Jaksch","year":"2005","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.trim.2011.06.001_bb0150","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12032-007-0002-3","article-title":"Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use?","volume":"24","author":"Deneberg","year":"2007","journal-title":"Medical Oncology"},{"key":"10.1016\/j.trim.2011.06.001_bb0155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.bmt.1705070","article-title":"Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion","volume":"36","author":"Narimatsu","year":"2005","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.1983.tb02839.x","article-title":"Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia","volume":"55","author":"Storb","year":"1983","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.trim.2011.06.001_bb0165","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","article-title":"Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0170","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","article-title":"Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling","volume":"321","author":"Gluckman","year":"1989","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.trim.2011.06.001_bb0175","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V88.3.795.795","article-title":"Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease","volume":"88","author":"Wagner","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbmt.2005.09.006","article-title":"Clinical use of umbilical cord blood hematopoietic stem cells","volume":"12","author":"Rocha","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0185","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","article-title":"The impact of anti-HLA antibodies on unrelated cord blood transplantations","volume":"116","author":"Takanashi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.trim.2011.06.001_bb0190","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.transproceed.2005.02.107","article-title":"Improved graft survival in ABO-incompatible living donor kidney transplantation","volume":"37","author":"Kaihara","year":"2005","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.trim.2011.06.001_bb0195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/01.TP.0000058226.39732.32","article-title":"ABO-incompatible kidney transplantation using both A2 and non-A2 living donors","volume":"75","author":"Gloor","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2011.06.001_bb0200","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1537-2995.2008.01678.x","article-title":"The impact of HLA antibodies on engraftment of unrelated cord blood transplants","volume":"48","author":"Takanashi","year":"2008","journal-title":"Transfusion"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327411000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327411000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T20:37:38Z","timestamp":1637959058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327411000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":40,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0966327411000475"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2011.06.001","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}